Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...

The official Microsoft 365 channel is the most reliable source for updated Copilot tutorials. It has dedicated playlists for ...